Dyslipidemia Flashcards

1
Q

What is the leading cause of death in the US?

A

Atherosclerosis (specifically CAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the basic process by which plaque forms?

A
  1. LDL brings cholesterol into the cell
  2. LDL is oxidized by reactive oxygen species (ROS)
  3. oLDL (oxidized LDL) is taken up by a macrophage & cholesterol is absorbed into macrophage forming a “foam cell”.
  4. Foam cell bursting & the resulting deposition of cholesterol forms the basis for plaque formation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two main lipids associated with CAD?

A
  • Cholesterol
  • Triglycerides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What lipid forms fat tissue/buildup & is the basis for metabolic syndrome?

A

Triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood levels of cholesterol are considered high at _______ mg/dL.

A

200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How long would it take to lower cholesterol, without a statin, through diet & lifestyle changes alone?

A

3-5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the synthesis pathway for cholesterol?

A

Acetyl-CoA → HMG-CoA → HMG CoA-reductase → Mevalonate → Cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the rate-limiting step in the cholesterol synthesis pathway?
Where do statin’s inhibit cholesterol formation?

A
  • Mevalonate
  • HMG-CoA reductase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the largest high-fat/low-protein lipoprotein?
Where are these made?
What do they carry?
Where are they degraded? What should be known about their degraded products?

A
  • Chylomicrons
  • GI tract.
  • Carry triglycerides & cholesterol
  • Degraded by cells, then liver; remnants are pro-atherogenic.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

VLDLs are secreted by what?
What are they converted to? How?

A
  • Liver
  • VLDLs are converted to IDLs & LDLs via the endogenous pathway.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

An excess of LDLs results in an excess of cholesterol in the ________.
How do HDLs differ from this?

A
  • Arteries
  • HDLs “scavenge” cholesterol from the arteries. ↓ HDLs are associated with atherosclerosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How are VLDL’s calculated?
How about LDL’s?

A

VLDL = Triglycerides/5
LDL = Total cholesterol - VLDL - HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What would a normal LDL/HDL ratio be?
What ratio would half one’s risk of CAD?
What ratio would double ones risk of CAD?

A

3 to 3.5
1 to 1.5
5 to 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What two factors can invalidate a measure LDL/HDL ratio?

A
  • Triglycerides greater than 400mg/dL
  • Chylomicrons present in sample
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What would a normal HDL level be in someone?

A

around 45 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Familial hypercholesterolemia involves increases levels of what?

A

LDLs

17
Q

What two conditions, highlighted in lecture, result in hypertriglyceridemia?

A
  • Diabetes Mellitus
  • EtOH abuse (↑ NADH)
18
Q

What three dietary intakes can be used to decrease risk of atherosclerosis? Give the reasoning why for each example.

A
  • ↓ cholesterol
  • ↓ fat, alcohol, & excess calories =↓ triglycerides
  • ↓ sucrose/fructose = ↓ VLDLs
19
Q

What other dietary measures can be utilized to help decrease risk of atherosclerosis?

A
  • 20% of calories from fat
  • ↑ fiber
  • weight reduction
  • ↑ intake of Ω-3 fatty acids.
20
Q

What is the most important hyperlipidemia medication?
What is the primary result of these drugs?
When are they prescribed?

A
  • Statins (HMG-CoA reducase inhibitors)
  • ↓ LDL & cholesterol levels
  • Prescribed with CAD symptoms regards of lipidemia.
21
Q

What are the 4 facets of a statin’s mechanism of action?

A
  1. ↓ cholesterol synthesis
  2. ↑ LDL reuptake (scavenged from liver)
  3. modest ↓ in triglycerides
  4. small ↑ in HDL
22
Q

When are statins typically administered? Why?
What is the dosing for pregnant & lactating women.

A
  • With food and/or at bedtime (cholesterol synthesis occurs at night.)
  • Not given to pregnant/lactating women.
23
Q

What are the two adverse outcomes of statin toxicity?

A
  1. ↑ liver enzymes (especially if patient is of asian descent)
  2. ↑ CK & muscle pain or weakness (typically minor but can be major)
24
Q

How does Niacin (Vitamin B₃) treat dyslipidemia?

A

Reduction of VLDL secretion from liver = ↓ VLDL/LDL & ↑ HDL.

25
Q

What does Niacin toxicity cause?

A
  • Cutaneous vasodilation (flushing)
  • ↑ liver enzymes
26
Q

How do Fibrates treat HLD?

A

↑ lipolysis in the liver

27
Q

How do Bile-acid binding resins work?
What is the prototypical drug of this class?
When are they given?
What can occur with other orally administered drugs if given with these?

A
  • BABRs bind to bile acids & prevent reabsorption of food.
  • Colesevalam HCl
  • Given with meals.
  • Decreased absorption of other PO drugs.
28
Q

How does Ezetimibe work?

A

Inhibition of sterol absorption in the intestine by blocking cholesterol transport.

29
Q

What is the one-sentence MOA of PCSK9 Inhibitors?

A

Prevention of LDL receptor from being recycled by inhibiting the PCSK9 molecule from tagging the receptor for destruction.

30
Q

What molecule targets an LDL receptor for destruction instead of recycling?

A

PCSK9

31
Q

PCSK9 Inhibitors with statins lower LDL levels by ______.

A

65%

32
Q

Gemfibrozil (lopid)

A

decreases VLDL
modest decrease in LDL
toxicity - rate (GI upset)
increases lipolysis in liver (PPAR)

33
Q

Evolocumab (Repatha)

A

LOWERED LDL 65%

mild allergy side effect (nasopharyngitis)

monoclonal antibodies - binds PCSK9, inhibit

injection 1x/2 weeks